CNS Pharmaceuticals Inc CNSP

Healthcare

CNS Pharmaceuticals, Inc. is a clinical-stage pharmaceutical company developing a pipeline of anti-cancer drug candidates for the treatment of primary and metastatic cancers of the brain and central nervous system (CNS). The Company's lead drug candidate, Berubicin, is a novel anthracycline and the first anthracycline to appear to cross the blood-brain barrier. Berubicin is in development for the treatment of a number of serious brain and CNS oncology indications, including glioblastoma multiforme (GBM), an aggressive and incurable form of brain cancer. In addition, the Company is advancing the development of its WP1244/WP1874 drug technology, which utilizes anthracycline and distamycin-based scaffolds to create small molecule agents. The Company is also evaluating the use of WP1244/WP1874 in the treatment of other primary brain and central nervous system cancers, as well as cancers metastatic to the brain including pancreatic, ovarian, and lymphomas.

NDAQ:CNSP - Post by User

CNS Pharmaceuticals Inc

<< Previous

Bullboard Posts

Next >>

Post by Iseneschalon Apr 14, 2023 5:57pm

193 Views

Post# 35396118

CNSP..... 9.0 mil shs have traded in AH

Last at $2.90
Who knows where this will close and also where it will open on Monday

I've been burnt a few times holding these Shitco's....then again I've been lucky to....mostly burnt though...they always seem to win

Maddapakkas !

<< Previous

Bullboard Posts

Next >>

Rig Count Soars as Utilization Surpasses Industry Averages